Results 351 to 360 of about 564,426 (377)
Some of the next articles are maybe not open access.
Critical Reviews in Oncogenesis, 2013
Anemia is a frequent finding of Hodgkin's lymphoma (HL) diagnosis. It is usually mild, with hemoglobin levels between 10 and 12 g/dl; it is rarely (
Hohaus, S +4 more
openaire +4 more sources
Anemia is a frequent finding of Hodgkin's lymphoma (HL) diagnosis. It is usually mild, with hemoglobin levels between 10 and 12 g/dl; it is rarely (
Hohaus, S +4 more
openaire +4 more sources
The Lymphomas: Hodgkin's Disease and Non-Hodgkin's Lymphomas
American Pharmacy, 1991This review presents an overview of a heterogeneous group of disorders that fall under the general heading of lymphomas. Many specific subtypes and presentations exist; their presentations, treatments, and prognoses vary greatly. Patients with lymphomas are generally treated with external beam radiation therapy, chemotherapy, or a combination of these ...
openaire +3 more sources
Hodgkin Lymphoma and Non-Hodgkin Lymphoma
2005Lymphomas account for 10% to 15% of malignancies in pediatric patients. The most common subtypes are Hodgkin lymphoma and non-Hodgkin lymphoma. The prognosis of both forms of lymphoma has improved significantly in the past 30 years. They are now the most “curable” forms of pediatric cancer.
Michael Rytting +3 more
openaire +2 more sources
Checkpoint Inhibitors Hodgkin Lymphoma and Non-Hodgkin Lymphoma
Current Hematologic Malignancy Reports, 2018The ligation of PD-1 with PD-L1 activates a critical immune checkpoint leading to T cell dysfunction, exhaustion, and tolerance. Anti-PD-1 or anti-PD-L1 monoclonal antibodies can reverse the immune checkpoint, releasing the brake on T cell responses.
Ryan Jacobs, Nilanjan Ghosh, Bei Hu
openaire +3 more sources
Hodgkin lymphoma: Pathology and biology.
Seminars in hematology (Print), 2016The Hodgkin and Reed-Sternberg (HRS) tumor cells of classical Hodgkin lymphoma (HL), as well as the lymphocyte predominant (LP) cells of nodular lymphocyte predominant HL (NLPHL), are derived from mature B cells.
S. Mathas, S. Hartmann, R. Küppers
semanticscholar +1 more source
Hodgkin's and Non-Hodgkin's Lymphomas
Radiologic Clinics of North America, 2007The diagnosis and management of lymphoma have undergone significant changes in the past 20 years. For example, new immunophenotypic and molecular methods have replaced traditional histology-based classification schemes for lymphoma. Fluorine-18-deoxyglucose (FDG) positron emission tomography (PET) has evolved into a potent staging tool and prognostic ...
openaire +3 more sources
Nodular lymphocyte-predominant Hodgkin lymphoma.
Seminars in hematology (Print), 2016Nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) is a rare subtype of Hodgkin lymphoma with distinct clinicopathologic features. It is typified by the presence of lymphocyte predominant (LP) cells, which are CD20(+) but CD15(-) and CD30(-) and are
K. Savage, A. Mottok, M. Fanale
semanticscholar +1 more source
Hematology, 2000
This review focuses on the different treatment options available for the treatment of Hodgkin's disease, with an emphasis on the importance of the long-term sequelae of these therapies. In Section I, Dr. Linch reviews the current status of Hodgkin's disease treatment.
David C. Linch +4 more
openaire +1 more source
This review focuses on the different treatment options available for the treatment of Hodgkin's disease, with an emphasis on the importance of the long-term sequelae of these therapies. In Section I, Dr. Linch reviews the current status of Hodgkin's disease treatment.
David C. Linch +4 more
openaire +1 more source
Cardiovascular disease after Hodgkin lymphoma treatment: 40-year disease risk.
JAMA Internal Medicine, 2015IMPORTANCE Hodgkin lymphoma (HL) survivors are at increased risk of cardiovascular diseases. It is unclear, however, how long the increased risk persists and what the risk factors are for various cardiovascular diseases.
Frederika A van Nimwegen +8 more
semanticscholar +1 more source
Nursing Standard, 2016
Essential facts Non-Hodgkin's lymphoma (NHL) is a cancer of the lymphatic system. According to Cancer Research UK, it is the sixth most common cancer in the UK, with 13,413 new cases diagnosed in 2013. There were 4,801 deaths from NHL in 2014. The disease has many subtypes, with two main broad categories: high-grade or aggressive and low-grade or ...
openaire +2 more sources
Essential facts Non-Hodgkin's lymphoma (NHL) is a cancer of the lymphatic system. According to Cancer Research UK, it is the sixth most common cancer in the UK, with 13,413 new cases diagnosed in 2013. There were 4,801 deaths from NHL in 2014. The disease has many subtypes, with two main broad categories: high-grade or aggressive and low-grade or ...
openaire +2 more sources